Agency Business briefs: September 2013

Share this article:
Alyse Sukalski
Alyse Sukalski

West Coast agency Giant Creative/Strategy promoted Alyse Sukalski to managing partner. She previously served as senior vice president. Prior to her time at Giant, Sukalski worked at FCB Healthcare and Alias Design Group.

Tonic Life Communications promoted five of its staff and hired seven employees. Notably, Stephanie DeViteri and Kelly Kutchinsky were bumped to senior vice president and Kata Callan was elevated to vice president.

Coyne Public Relations added to its healthcare roster bringing in Todd Forte as vice president and Amanda Love as account supervisor. Forte previously worked with a privately owned healthcare communications agency in New Jersey. Love joins from Fleishman-Hillard, London, where she worked on such accounts as Bayer, Novartis, GSK and UCB.

Spectrum Science promoted Lissette Capati to senior vice president and Megan Lustig to vice president. Capati will oversee all business ­development and ­supervise marketing activities for the agency. Lustig will focus on work with clients Proctor & Gamble and the Kennedy Krieger Institute.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?